Dr. Sailaja Kamaraju
Claim this profileMedical College of Wisconsin (Milwaukee)
Studies Breast Cancer
Studies Skin Cancer
6 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
ER positive
2Skin Cancer
ER
PR
HER2/neu
Affiliated Hospitals
Clinical Trials Sailaja Kamaraju is currently running
Intermittent Fasting
for Breast Cancer
This single-arm study is designed to test the hypothesis that a six-month intermittent fasting (IF) intervention is feasible for patients to adhere to and improves health-related quality of life while subjects are on adjuvant endocrine therapy (AET).
Recruiting1 award N/A14 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
More about Sailaja Kamaraju
Clinical Trial Related8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sailaja Kamaraju has experience with
- Placebo
- Intermittent Fasting
- Pertuzumab
- Trastuzumab
- Tucatinib
- Additional Support Program Via Text Messaging And Telephone-Based Counseling
Breakdown of trials Sailaja Kamaraju has run
Breast Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sailaja Kamaraju specialize in?
Sailaja Kamaraju focuses on Breast Cancer and Skin Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sailaja Kamaraju currently recruiting for clinical trials?
Yes, Sailaja Kamaraju is currently recruiting for 3 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Sailaja Kamaraju has studied deeply?
Yes, Sailaja Kamaraju has studied treatments such as Placebo, Intermittent Fasting, Pertuzumab.
What is the best way to schedule an appointment with Sailaja Kamaraju?
Apply for one of the trials that Sailaja Kamaraju is conducting.
What is the office address of Sailaja Kamaraju?
The office of Sailaja Kamaraju is located at: Medical College of Wisconsin (Milwaukee), Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin (Milwaukee).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.